The latest on IgG4-RD: A rapidly emerging disease

Current Opinion in Rheumatology

Volumn 24, Issue 1, 2012, Pages 60-69

  Carruthers, Mollie N ^a   Stone, John H ^b   Khosroshahi, Arezou ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Autoimmune pancreatitis; IgG4; IgG4 related disease; IgG4 related systemic disease

Indexed keywords

IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; DRUG DOSE REDUCTION; EOSINOPHILIC ANGIOCENTRIC FIBROSIS; FIBROSIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC CERVICAL FIBROSIS; IGG4 RELATED DISEASE; IMMUNE MEDIATED INJURY; INTERSTITIAL NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MESENTERITIS; MIDDLE EAR EFFUSION; NOMENCLATURE; ORBIT INFLAMMATION; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PSEUDOTUMOR; REACTIVE NODULAR FIBROUS PSEUDOTUMOR; REVIEW; SCLEROSING ANGIOMATOID NODULAR TRANSFORMATION; SCLEROSING CHOLANGITIS; SPLEEN DISEASE;

HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; PARAPROTEINEMIAS;

EID: 82955237241     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834ddb4a     Document Type: Review

References (45)

1. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4 related systemic disease. Arthritis Rheum 2010; 62:1755-1762.
2. Khosroshahi A, Stone JH. Treatment approaches to IgG4 related systemic disease. Curr Opin Rheumatol 2011; 23:67-71.
3. Khosroshahi A, Stone JH. A clinical review of IgG4 related systemic disease. Curr Opin Rheumatol 2011; 23:57-66.
4. Masaki Y, Kurose N, Umehara H. IgG4 related disease: A novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop 2011; 51:13-20.
5. Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4 related systemic disease spectrum. Arthritis Care Res (Hoboken) 2010; 62:1312-1318.
6. The Reports of the Grant from the Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare (H21-Nanchi-Ippann-112, representative Umehara H) [in Japanese].
7. Harrison JD, Rodriguez-Justo M. Commentary on IgG4 related sialadenitis: Mikulicz's disease, Kuttner's tumour, and eponymy. Histopathology 2011; 58:1164-1166.
8. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised nonspecific chronic inflammatory conditions and need to be distinguished from IgG4 related systemic disorders. J Clin Pathol 2011; 64:237-243.
9. Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4 related tubulointerstitial nephritis. J Am Soc Nephrol 2011; 22:1343-1352. An important study of IgG4 related kidney disease.
10. Tabata T, Kamisawa T, Takuma K, et al. Serial changes of elevated serum IgG4 levels in IgG4 related systemic disease. Intern Med 2011; 50:69-75.
11. Shimosegawa T, Chari ST, Frulloni L, et al., International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352-358.
12. Chari ST, Kloeppel G, Zhang L, et al., The Autoimmune Pancreatitis International Cooperative Study Group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: The Honolulu consensus document. Pancreas 2010; 39:549-554.
13. Smyrk TC. Pathological features of IgG4 related sclerosing disease. Curr Opin Rheumatol 2011; 23:74-79.
14. Okazaki K, Uchida K, Miyoshi H, et al. Recent concepts of autoimmune pancreatitis and IgG4 related disease. Clin Rev Allergy Immunol 2011; 41:126-138.
15. Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4 related disease. J Gastroenterol 2011; 46:277-288.
16. Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4 related disease: Lessons from ten consecutive patients. Medicine (in press).
17. Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4 related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol 2010; 128:577-584.
18. Plaza JA, Garrity JA, Dogan A, et al. Orbital inflammation with IgG4-positive plasma cells: Manifestation of IgG4 systemic disease. Arch Ophthalmol 2011; 129:421-428.
19. Wallace ZS, Khosroshahi A, Jakobiec FA,et al. IgG4 related systemic disease as a cause of 'idiopathic' orbital inflammation, including orbital myositis and trigeminal nerve involvement. Surv Ophthalmol 2011 [Epub ahead of print].
20. Cho HK, Lee YJ, Chung JH, Koo JW. Otologic manifestation in IgG4 related systemic disease. Clin Exp Otorhinolaryngol 2011; 4:52-54.
21. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Ann Intern Med 1967; 66:884-892.
22. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52:683-687. (Pubitemid 36528870)
23. Patel PC, Pellitteri PK, Vrabec DP, Szymanski M. Tumefactive fibroinflammatory lesion of the head and neck originating in the infratemporal fossa. Am J Otolaryngol 1998; 19:216-219. (Pubitemid 28223906)
24. Cheuk W, Tam FK, Chan AN, et al. Idiopathic cervical fibrosis: A new member of IgG4 related sclerosing diseases - report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol 2010; 34:1678-1685.
25. Roberts PF, McCann BG. Eosinophilic angiocentric fibrosis of the upper respiratory tract: A mucosal variant of granuloma faciale: - a report of three cases. Histopathology 1985; 9:1217-1225. (Pubitemid 16213212)
26. Deshpande V, Khosroshahi A, Nielsen GP, et al. Eosinophilic angiocentric fibrosis is a form of IgG4 related systemic disease. Am J Surg Pathol 2011; 35:701-706.
27. Chetty R, Serra S, Gauchotte G, et al. Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cells. Pathology 2011; 43:31-35.
28. Akram S, Pardi DS, Schaffner JA, Smyrk TC. Sclerosing mesenteritis: Clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol 2007; 5:589-596. (Pubitemid 46660775)
29. Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4 related sclerosing disorders? J Clin Pathol 2008; 61:1093-1097.
30. Nomura Y, Naito Y, Eriguchi N, et al. A case of IgG4 related sclerosing mesenteritis. Pathol Res Pract 2011; 207:518-521.
31. Mannion M, Cron RQ. Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: Case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J 2011; 9:1.
32. Swain RS, Tihan T, Horvai AE, et al. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol 2008; 39:410-419. (Pubitemid 351186689)
33. Saab ST, Hornick JL, Fletcher CD, et al. IgG4 plasma cells in inflammatory myofibroblastic tumor: Inflammatory marker or pathogenic link? Mod Pathol 2011; 24:606-612.
34. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007; 31:1586-1597. (Pubitemid 47482474)
35. Beck LH, Bonegio RGB, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
36. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4 related systemic disease. Am J Surg Pathol 2006; 30:1472-1477. (Pubitemid 44655485)
37. Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4 related tubulointerstitial nephritis. Kidney Int 2010; 78:1016-1023.
38. Cravedi P, Abbate M, Gagliardini E, et al. Membranous nephropathy associated with IgG4 related disease. Am J Kidney Dis 2011; 58:272-275.
39. Fervenza FC, Downer G, Beck LH Jr, Sethi S. IgG4 related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis 2011; 58:320-324.
40. Debiec H, Lefeu F, Kemper MJ, et al. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 2011; 364:2101-2110.
41. Kuo TT, Chen TC, Lee LY. Sclerosing angiomatoid nodular transformation of the spleen (SANT): Clinicopathological study of 10 cases with or without abdominal disseminated calcifying fibrous tumors, and the presence of a significant number of IgG4+ plasma cells. Pathol Int 2009; 59:844-850.
42. Kashiwagi S, Kumasaka T, Bunsei N. Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen. Virchows Arch 2008; 453:275-282.
43. Nagai Y, Hayama N, Kishimoto T, et al. Predominance of IgG4+ plasma cells and CD68 positivity in sclerosing angiomatoid nodular transformation (SANT). Histopathology 2008; 53:495-498.
44. Tomiyama T, Uchida K, Matsushita M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol 2011; 46:696-704.
45. Björnsson E, Chari S, Silveira M, et al. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: Clinical characteristics and response to therapy. Am J Ther 2011; 18:198-205.